Drug Shortage Report for APO-DIVALPROEX

Last updated on 2017-07-26 History
Report ID 12805
Drug Identification Number 02239699
Brand name APO-DIVALPROEX
Common or Proper name DIVALPROEX
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) VALPROIC ACID
Strength(s) 250MG
Dosage form(s) TABLET (ENTERIC-COATED)
Route of administration ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 100 BTL
ATC code N03AG
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-06-23
Actual start date 2017-06-19
Estimated end date 2017-07-31
Actual end date 2017-07-25
Shortage status Resolved
Updated date 2017-07-26
Company comments APO-DIVALPROEX 250 MG ECT 500 BTL is available
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2017-07-26 French Compare
v8 2017-07-26 English Compare
v7 2017-07-11 French Compare
v6 2017-07-11 English Compare
v5 2017-06-20 English Compare
v4 2017-06-19 French Compare
v3 2017-06-19 English Compare
v2 2017-06-15 French Compare
v1 2017-06-15 English Compare

Showing 1 to 9 of 9